Manufacturer record
Stallion Laboratories Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
4 batches manufactured by Stallion Laboratories Pvt. Ltd (Gujarat) were declared Not of Standard Quality between May 2020 and June 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
4 records linked to Stallion Laboratories Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Glipizide Tablets I.P. 5 mg | T3180Mfg 2023-03 · Exp 2025-02 | DissolutionDissolution | CDL KolkataCDSCO lab | Jun 2023 |
| Budecort Respules 0.5 mg (Budesonide Nebuliser Suspension B.P.) | IA20131Mfg 2022-02 · Exp 2024-01 | AssayAssay | CDL KolkataCDSCO lab | Jan 2023 |
| Albendazole Tablets IP 400 mg | T3037Mfg 2022-08 · Exp 2024-07 | DissolutionDissolution | CDL KolkataCDSCO lab | Nov 2022 |
| Onstal - 4 (Ondansetron Tablets IP 4 mg) | T2227Mfg 2018-08 · Exp 2020-07 | DescriptionDescription | CDL KolkataCDSCO lab | May 2020 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.